Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Revenue Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn 19.91%
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn 15.10%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn 12.23%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - -4.00%
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.23%
Mar 31, 2026 12.91%
Dec 31, 2025 11.41%
Sep 30, 2025 11.39%
Jun 30, 2025 10.77%
Mar 31, 2025 5.87%
Dec 31, 2024 6.98%
Sep 30, 2024 11.51%
Jun 30, 2024 17.15%
Mar 31, 2024 20.30%
Dec 31, 2023 66.68%
Sep 30, 2023 19.11%
Jun 30, 2023 21.63%
Mar 31, 2023 18.74%
Dec 31, 2022 21.49%
Sep 30, 2022 21.44%
Jun 30, 2022 22.22%
Mar 31, 2022 27.74%
Dec 31, 2021 25.85%
Sep 30, 2021 22.76%